Safi Biotherapeutics Inc | $5,000,000 | (Sep 13, 2024)
Cavela | $2,000,000 | (Sep 13, 2024)
AceUp | $22,500,000 | (Sep 13, 2024)
Certified by Founder
Lodge
IRUBIS
start up
Germany
- Munich, Bavaria
- 03/09/2024
- Pre Series A
- Undisclosed Amount
IRUBIS | Innovative Process Analytical Spectroscopy for Biomanufacturing.
IRUBIS is a company that specializes in mid-infrared (MIR) spectroscopy for bioprocessing. We have designed an instrument, Monipa, specifically for bioprocess monitoring and control.
Monipa is based on MIR spectroscopy, making it possible to monitor multiple bioprocesses real-time and continuously. Our instrument's applications are foreseen in both upstream and downstream bioprocessing. These include multiple metabolite monitoring and control in upstream processing. In addition, contaminant detection or monitoring of target proteins and excipients can be aided in downstream processing.
Read more about our products and innovations at www.irubis.com.
- Industry Biotechnology Research
- Website https://irubis.com/
- LinkedIn https://www.linkedin.com/company/irubis/
Inflammatix, Inc. | $57,000,000 | (Sep 13, 2024)
xMap | Undisclosed Amount | (Sep 13, 2024)
Gestalt | $5,900,000 | (Sep 13, 2024)
Jus Mundi | $22,000,000 | (Sep 13, 2024)
Realm.Security, Inc | $5,000,000 | (Sep 13, 2024)
PathPresenter | $7,500,000 | (Sep 13, 2024)
F2G | $100,000,000 | (Sep 13, 2024)
Ucaneo | $7,475,895 | (Sep 13, 2024)
Cohora | $2,500,000 | (Sep 13, 2024)
Reshape Automation | $5,000,000 | (Sep 13, 2024)